Big Move For TransCode Therapeutics Inc.
Mon, Sep 25, 2023 at 07:31 PM
TransCode Therapeutics Inc. (RNAZ:NASDAQ) rocketted at $2.55, representing a gain of 284%. On Mon, Sep 25, 2023, RNAZ:NASDAQ touched a New 2-Week High of $2.55. The stock appeared on our News Catalysts scanner on Mon, Sep 25, 2023 at 08:38 AM in the 'BIOTECH' category. From Mon, Sep 11, 2023, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Mon, Sep 25, 2023 at $3.2 with a volume of 95M+.
About TransCode Therapeutics Inc. (RNAZ:NASDAQ)
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.
Top 10 Gainers:
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 284.04%
- IronNet Inc. (IRNT:NYSE), 98.02%
- Vaccitech plc (VACC:NASDAQ), 90.36%
- Digital Transformation Opportunities Corp. (DTOC:NASDAQ), 89.56%
- Biophytis SA (BPTS:NASDAQ), 72.83%
- Polished Inc Com (POL:NYSEMKT), 40.11%
- BYND Cannasoft Enterprises Inc. (BCAN:NASDAQ), 37.29%
- Avalo Therapeutics Inc. (AVTX:NASDAQ), 36.75%
- Yunji Inc. (YJ:NASDAQ), 31.44%
- Digital Media Solutions Inc. Class A (DMS:NYSE), 28.64%